New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
10:18 EDTCI, UNH, WLP, WCG, HUM, HNT, UAM, AETCMS says Medicare Advantage reimbursement to rise in 2015
The Centers for Medicare & Medicaid Services announced Medicare Advantage and prescription drug rates for 2015. The agency estimated that its payments for Medicare Advantage beneficiaries would rise slightly, versus its previous estimate that such payments would fall. A Medicare Advantage Plan is a type of health plan offered by a private company that contracts with Medicare to provide subscribers with Part A and Part B benefits. WHAT'S NEW: CMS reimbursements for Medicare Advantage beneficiaries will rise 0.4%, CMS estimated, compared to a February proposal that contemplated a 1.9% cut. ANALYST REACTION: In a note to investors earlier today, FBR Capital analyst Steven Halper wrote that the final Medicare Advantage rates are a positive for health insurers with significant exposure to such plans. Companies in this category include Aetna (AET), Humana (HUM), and UnitedHealth (UNH), said Halper. He kept Outperform ratings on Aetna and United Health and a Market Perform rating on Humana. Another research firm, Leerink, said it views the "biggest positive" from the final rates that the CMS announced last night as the delay in the proposal to eliminate in home Health Risk Assessments to support reimbursement for high risk seniors. Leerink thinks the final rates are favorable for MA plans and estimates the positive impact in order: Humana, Universal American (UAM), WellCare (WCG), UnitedHealth, Cigna (CI), Aetna, Health Net (HNT) and WellPoint (WLP). PRICE ACTION: In early trading, Aetna rose fractionally to $72.70, UnitedHealth lost 0.6% to $80.59, Humana sank 1.8% to $109.95, and Universal American added 2c to $7.16.
News For AET;HUM;UNH;UAM;WCG;CI;HNT;WLP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 15, 2015
11:08 EDTHUMOmega Advisors gives quarterly update on stakes
NEW STAKES: Targa Resources (TRGP), Targa Resources Partners (NGLS), Humana (HUM), Dow Chemical (DOW), and Twenty-First Century Fox (FOXA). INCREASED STAKES: Kinder Morgan (KMI), Chimera Investment Corporation (CIM), AerCap Holdings (AER), Shire (SHPG), and KKR & Co. (KKR). DECREASED STAKES: eBay (EBAY), Altisource Portfolio Solutions (ASPS), Caesars Entertainment (CZR), Navient (NAVI), and TerraForm Power (TERP). LIQUIDATED STAKES: HCA Holdings (HCA), Gilead (GILD), Cabot Oil & Gas (COG), and Apple (AAPL).
07:32 EDTWCGWellCare valuation compelling after selloff, says Leerink
Leerink views the valuation of WellCare shares as compelling following the company's "solid" Q1 results. The firm reiterates an Outperform rating on the stock with a $105 price target.
May 14, 2015
07:33 EDTUNHUnitedHealth would consider Optum spinoff if benefits erode, says UBS
Subscribe for More Information
May 13, 2015
11:22 EDTHUMOptions with increasing implied volatility
Subscribe for More Information
10:18 EDTCI, HUM, AETAnalyst says sell Humana amid 'wishful' takeover speculation
Subscribe for More Information
10:01 EDTHUMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:12 EDTCI, HUMHumana downgraded to Underperform from Neutral at Sterne Agee CRT
Sterne Agee CRT analyst Brian Wright downgraded Humana (HUM) to Underperform saying speculation about a takeover is "wishful thinking" at current share levels. The stock rallied 4% yesterday after Leerink told investors that Aetna (AET) may acquire Humana or Cigna (CI) in the near-term. Wright also sees "material" risk to Humana's earnings guidance risk with paid claims outpacing premium growth. He lowered his price target for shares to $150 from $165. Humana shares closed yesterday up $6.76 to $173.38.
May 12, 2015
15:46 EDTHUMHumana May volatility increases on sharp rally
Subscribe for More Information
15:39 EDTCICigna May volatility elevated
Cigna May call option implied volatility is at 35, June is at 28, and August is at 30; compared to its 90-day average of 31, suggesting large near term price movement.
13:03 EDTAETAetna repeats view of FY15 operating EPS $7.20-$7.40, consensus $7.38
Subscribe for More Information
11:53 EDTHUM, CI, AETAnalyst predicts large transaction 'imminent' for Aetna
Subscribe for More Information
10:28 EDTHUMOptions with increasing implied volatility: YELP HUM LULU CTRX
Subscribe for More Information
10:04 EDTHUM, AETHigh option volume stocks
Subscribe for More Information
09:53 EDTHUM, AETAetna merger with Cigna or Humana likely 'imminent,' says Leerink
Subscribe for More Information
07:35 EDTHNTBofA/Merrill to hold a conference
Subscribe for More Information
May 11, 2015
15:06 EDTAETAetna backs FY15 operating EPS $7.20-$7.40, consensus $7.38
In a regulatory filing earlier, Aetna reported that during upcoming investor meetings in May, the company expects to reaffirm its FY15 operating EPS guidance of $7.20-$7.40. Current FY15 EPS consensus is $7.38.
07:40 EDTUNHFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertexís Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasnít announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
07:22 EDTWCGWellCare recent selloff presents buying opportunity, says Susquehanna
Subscribe for More Information
07:13 EDTUNHUnitedHealth management to meet with UBS
Subscribe for More Information
06:51 EDTAETAetna management to meet with Leerink
Meeting to be held in Hartford, CT on May 11 hosted by Leerink.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use